You are here: >  Home Page > Shop >


The abstract of this article is free to access. Subscribers to this volume should login to gain access to the article; non-subscribers can either purchase the article or a subscription.

View basket / Proceed to Checkout

Original article

Interim analysis of a 3-year follow-up study of NS5A and NS3 resistance-associated substitutions after treatment with grazoprevir-containing regimens in participants with chronic HCV infection

Frederick Lahser, Angela Galloway, Peggy Hwang, John Palcza, Joann Brunhofer, Janice Wahl, Michael Robertson, Eliav Barr, Todd Black, Ernest Asante-Appiah, Barbara Haber

Antiviral Therapy 2018; 23:593-603
Cost: £20.00 excl. VAT

< Back to Previous page
Copyright © 2019 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.